Original air date: Wednesday, May 3, 2017 1:00 - 2:30 PM EDT
Despite significant advances in HIV prevention and care for people living with HIV/AIDS in the U.S., the annual rate of new infections has remained at approximately 50,000 over many years. In an effort to decrease new infections, groundbreaking scientific work has expanded the use of antiretroviral medications for individuals at high risk for HIV to prevent infection - pre exposure prophylaxis (PrEP).
This webinar will include a review of the literature on PrEP; the rationale and indications for prescription use and current recommendations; its efficacy, the risk for compensatory behaviors, and reducing risk for other sexually transmitted infections (STI). The webinar will also demonstrate and discuss the unique role for mental health providers in the use of PrEP.
- Describe the evidence-base that supports the efficacy of PrEP
- Understand key characteristics of individuals who may benefit from PrEP and identify certain factors of individuals who may not benefit from PrEP
- Discuss potential barriers to the use of PrEP and identify strategies to help patients overcome barriers
- List strategies that mental health providers can employ to engage patients in conversations regarding the pros, cons and potential outcomes of proper PrEP use
The American Psychiatric Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. In order to receive CME credit, participants must fill out the feedback survey listed below. Upon completion of the survey, participants will receive a code as well as further instructions to be followed at the APA website.
For more information, contact Roke Iko at email@example.com.
Kenneth Ashley, M.D. is an Assistant Professor of Clinical Psychiatry at the Icahn School of Medicine at Mount Sinai (Clinician/Educator track) and Co-Director of Mental Health Services in the Peter Krueger Center for Immunological Disorders at Mount Sinai Beth Israel Hospital, a division of the Institute for Advanced Medicine. Dr. Ashley is also an attending psychiatrist in the Division of Consultation-Liaison Psychiatry and Psychosomatic Medicine at Mount Sinai Beth Israel.
Dr. Ashley graduated from Stanford University, received his medical degree from Jefferson Medical College, completed his psychiatric residency training at Beth Israel Medical Center, then he completed a two year research fellowship in C-L Psychiatry/Psychosomatic Medicine at Beth Israel Medical Center and NYU Medical School/Bellevue Hospital Center.
Dr. Ashley is board certified in General Psychiatry and Psychosomatic Medicine. In addition to his clinical responsibilities, Dr. Ashley teaches and mentors Psychosomatic Medicine fellows, Psychiatric residents, and medical students. At Mount Sinai Beth Israel Dr. Ashley is a member of the Ethics Committee, Co-Chair of the LGBT Employee Resource Group, and a member of the Diversity Council.
Dr. Ashley is a Distinguished Fellow of the APA and alumni of the APA/NIMH Minority Fellowship. He has been active in the APA at both the local (NY County Psychiatric Society-NYCPS) and the national levels. He is the former President of the NYCPS, a current Assembly Representative, and active on various committees, including the LGBT Issues and AIDS Committees. At the national level he has been involved with both the Committee on GLB Issues and is a member of the AIDS Committee/APIRE (American Psychiatric Institute for Research and Education) HIV Psychiatry Steering Committee, as well as a Site Director for the APA Minority Medical Student HIV Psychiatry elective.
He is the former President of the Association of Gay and Lesbian Psychiatrists and the Society for Liaison Psychiatry, the New York metro area component of the Academy of Psychosomatic Medicine (APM). He is a Senior Fellow of the Group for the Advancement of Psychiatry (GAP) and member of the LGBT Committee, and a member of the Executive Council of the World Psychiatric Association (WPA) Section on HIV/AIDS.
Dr. Ashley has presented on issues in HIV, LGBT, and cultural diversity both nationally and internationally, as well as written on these issues.
Click here to access our feedback survey!